MassimoDomenicoFedericoMD

Clinical Trials

• Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Start of enrollment: 2003 Aug 27

  Completed

  Phase 3

• Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL. Start of enrollment: 2002 Oct 01

  Unknown status

  Phase 2

• Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma Start of enrollment: 2005 Dec 01

  Unknown status

  Phase 3

• HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy Start of enrollment: 2000 Oct 01

  Completed

  Phase 3

• Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory Start of enrollment: 2009 May 01

  Terminated

• Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters Start of enrollment: 2009 Apr 01

  Unknown status

• Gonadal Toxicity in Women With Hodgkin Lymphoma Start of enrollment: 2009 Jul 01

  Unknown status

• Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma Start of enrollment: 2010 May 01

  Unknown status

  Phase 2

• The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy Start of enrollment: 2009 May 01

  Completed

• Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma Start of enrollment: 2012 Jul 01

  Completed

  Phase 3

• Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma. Start of enrollment: 2018 Oct 14

  Recruiting

• Join now to see all